Low Grade Squamous Intraepithelial Lesion (LSIL) of the Anus and Anal Canal: Understanding Your Pathology Report

Section Editor: David Driman
November 10, 2026


Print this article

Low grade squamous intraepithelial lesion (LSIL) of the anus and anal canal is a change in the cells lining the anus that is caused by infection with human papillomavirus (HPV). The abnormal cells stay within the surface lining and have not grown into the tissue below, so LSIL is not cancer. It is the lowest-risk result in the group of HPV-related changes found in the anus, and it carries only a small risk of turning into cancer.

Other names for this diagnosis include anal intraepithelial neoplasia 1 (AIN1), low-grade dysplasia, and mild dysplasia. When LSIL forms a raised, wart-like growth, it may be called a condyloma or anal wart.

This article explains what low grade squamous intraepithelial lesion of the anus means and how it differs from high grade lesions. It also explains the p16 result on your report and what usually happens after this diagnosis.

What causes low grade squamous intraepithelial lesion of the anus?

Low grade squamous intraepithelial lesion of the anus is caused by HPV infecting the squamous cells that line the anus and anal canal. HPV is a very common virus that is passed by skin-to-skin contact during sexual activity. Most people are infected at some point in their lives, and most infections clear on their own without causing problems.

LSIL can be caused by low-risk types of HPV, such as types 6 and 11, which are also the usual cause of anal and genital warts. It can also be caused by high-risk types such as HPV 16. In an LSIL, the virus mainly makes copies of itself and has not taken control of the cell’s growth the way it does in a high-grade lesion.

LSIL is more common in people whose immune system has trouble clearing HPV. This includes people living with HIV and people who take medicines that suppress the immune system after an organ transplant.

What are the symptoms of low grade squamous intraepithelial lesion of the anus?

Low grade squamous intraepithelial lesion of the anus usually causes no symptoms. It is most often found during anal cancer screening, or when the anus is examined for another reason such as hemorrhoids. When LSIL forms a wart, a person may notice a small bump, itching, or minor bleeding.

How is the diagnosis made?

A pathologist diagnoses low-grade squamous intraepithelial lesion of the anus by examining a tissue sample under a microscope. The process often starts with a screening test, such as an anal Pap test or an HPV test, taken with a swab. An abnormal screening result may lead to high-resolution anoscopy. This is a magnified examination of the anal canal that helps the doctor find abnormal areas and take a small biopsy.

Under the microscope, the abnormal squamous cells in LSIL are limited to the lower third of the epithelium, the thin surface lining. Cells closer to the surface still mature fairly normally, and many surface cells show virus-related changes. These infected cells, called koilocytes, have a large, dark, wrinkled nucleus surrounded by a clear halo. No abnormal cells have broken through the lining into the tissue below.

Some biopsies also contain a raised, wart-like growth called a condyloma acuminatum. Under the current terminology, a condyloma is considered a form of LSIL. In some cases, the pathologist uses a test called p16 to distinguish LSIL from a high-grade lesion, as described below.

Low grade versus high grade

Low grade squamous intraepithelial lesion is one of two grades of HPV-related precancerous change in the anus. Since 2012, pathologists have used a two-tier system from the Lower Anogenital Squamous Terminology (LAST) project, which the World Health Organization (5th edition, 2019) also follows. Your report may use either the current or the older names:

  • Low grade squamous intraepithelial lesion (LSIL). This is the same as AIN1. The abnormal cells fill only the lower part of the lining, and the risk of cancer is very low. Many of these lesions go away on their own as the immune system clears the virus.
  • High-grade squamous intraepithelial lesion (HSIL). This includes what used to be called AIN2 and AIN3. The abnormal cells fill more of the lining, and the virus has taken control of cell growth. HSIL carries a higher risk of turning into cancer and is usually treated.

A lesion that looks like AIN2 under the microscope is placed in one group or the other based on the p16 result. If p16 is negative, the lesion is reported as LSIL. Some reports still list the older AIN number next to the LSIL or HSIL diagnosis.

Immunohistochemistry for p16

Immunohistochemistry uses antibodies to show which proteins cells make. For a low grade squamous intraepithelial lesion of the anus, the pathologist may test for a protein called p16. Cells make large amounts of p16 when a high-risk HPV type has taken control of their growth. The test is usually done when the microscope alone cannot determine whether a lesion is low grade or high grade. Your report may describe the result in one of these ways:

  • Negative. The cells do not stain, or only a few scattered cells stain. This result supports a diagnosis of LSIL, and most LSILs are p16-negative.
  • Patchy or non-block positive. Some cells stain, but not in a continuous band. This pattern also supports LSIL rather than HSIL.
  • Block positive. Strong staining fills a continuous band of cells starting at the bottom of the lining. This pattern supports HSIL. A lesion with this result is not usually reported as LSIL.

Not every biopsy needs a p16 test, and when the microscopic appearance is clearly low grade, the pathologist may diagnose it without it.

Surgical margins

A margin is the cut edge of tissue removed from the anus. Margins are described only when a low-grade squamous intraepithelial lesion has been removed completely, for example, when a wart is excised. Most small biopsies are not intended to remove the whole lesion, so margins are usually not reported.

  • Negative margin. No LSIL is seen at the cut edge of the tissue, which suggests the lesion was completely removed.
  • Positive margin. LSIL extends to the cut edge of the tissue, so that some abnormal cells may remain. Because LSIL is low risk and often resolves on its own, a positive margin usually does not change the plan, but your doctor will consider it during follow-up.

What is the risk of developing cancer?

The risk that a low grade squamous intraepithelial lesion of the anus will turn into cancer is very low. Many LSILs go away on their own as the immune system clears HPV. A smaller number stay the same for years, and only a few progress to HSIL. Cancer usually develops from HSIL rather than directly from LSIL, and usually only after many years.

Some factors raise the chance that LSIL will persist or progress:

  • A weakened immune system. People living with HIV, especially when it is not well controlled, and organ transplant recipients clear HPV less easily.
  • High-risk HPV types. Lesions caused by types such as HPV 16 are more likely to progress than those caused by HPV 6 or 11.
  • Smoking. Tobacco use is linked to a higher risk of anal precancer and anal cancer.

What happens after the diagnosis?

Once low grade squamous intraepithelial lesion of the anus has been confirmed by biopsy, the next steps depend on your overall risk of anal cancer. Your symptoms and whether any high-grade lesions were also found are also considered. Your doctor may consider:

  • Observation and repeat screening. LSIL alone does not usually need treatment. Many people continue routine anal cancer screening at an interval set by their doctor. Since 2024, international screening guidelines recommend regular screening for groups at higher risk, such as people living with HIV.
  • Treatment of warts. When LSIL forms warts that cause symptoms, they may be treated, for example, with creams applied to the skin, freezing, or removal.
  • Closer follow-up. People with a weakened immune system, or with HSIL elsewhere in the anus, may be examined more often with high-resolution anoscopy.
  • Treatment of any high-grade lesion. If HSIL is found at the same time, it is usually treated. A large trial published in 2022 showed that treating HSIL in people with HIV lowered their risk of anal cancer by more than half.

The HPV vaccine protects against the HPV types that cause most anal cancers and warts. Your doctor can tell you whether vaccination is recommended.

Questions to ask your doctor

  • Does my report say LSIL, AIN1, or condyloma?
  • Was a p16 test done, and what was the result?
  • Was any high-grade lesion (HSIL) found in my biopsies?
  • Do you know which HPV type caused this lesion?
  • Does this lesion need any treatment, or will we watch it?
  • If a wart was removed, were the margins clear?
  • How often should I have anal cancer screening or anoscopy?
  • Does my immune status change how closely I need to be followed?
  • Would the HPV vaccine benefit me?
  • What symptoms should prompt me to contact you before my next visit?

Related articles on MyPathologyReport.com

A+ A A-
Was this article helpful?